Archive


Category: BTG

  • Boston Scientific to Divest BTG’s Specialty Pharma Business for ~$800M

    Shots: Boston Scientific signs an agreement with Stark International and SERB SAS to sell its BTG specialty pharma business for $800M in cash. The transaction is expected to close in H1’21 The agreement includes the transfer of 5 facilities & ~280 employees globally. This transaction will help the BTG specialty pharma business enhance its potential […]